Shagun Singh
Stock Analyst at RBC Capital
(3.36)
# 1,065
Out of 5,111 analysts
246
Total ratings
51.71%
Success rate
1.97%
Average return
Main Sectors:
Stocks Rated by Shagun Singh
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| BSX Boston Scientific | Maintains: Outperform | $125 → $130 | $92.95 | +39.86% | 18 | Dec 17, 2025 | |
| BDX Becton, Dickinson and Company | Maintains: Sector Perform | $202 → $210 | $196.39 | +6.93% | 4 | Dec 17, 2025 | |
| JNJ Johnson & Johnson | Maintains: Outperform | $209 → $230 | $209.30 | +9.89% | 23 | Dec 11, 2025 | |
| EW Edwards Lifesciences | Maintains: Outperform | $95 → $100 | $85.32 | +17.21% | 24 | Dec 5, 2025 | |
| PODD Insulet | Maintains: Outperform | $370 → $380 | $288.73 | +31.61% | 4 | Nov 21, 2025 | |
| MDT Medtronic | Maintains: Outperform | $111 → $118 | $97.72 | +20.75% | 22 | Nov 19, 2025 | |
| OM Outset Medical | Maintains: Sector Perform | $22 → $17 | $3.92 | +333.67% | 14 | Nov 11, 2025 | |
| TFX Teleflex | Maintains: Sector Perform | $135 → $120 | $124.87 | -3.90% | 23 | Nov 7, 2025 | |
| GMED Globus Medical | Maintains: Outperform | $88 → $92 | $85.79 | +7.24% | 6 | Nov 7, 2025 | |
| ZBH Zimmer Biomet Holdings | Maintains: Outperform | $111 → $101 | $90.91 | +11.10% | 17 | Nov 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $150 → $125 | $115.51 | +8.22% | 7 | Nov 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $100 → $85 | $66.37 | +28.07% | 5 | Oct 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $615 → $625 | $554.58 | +12.70% | 17 | Oct 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Outperform | $147 | $126.86 | +15.88% | 17 | Oct 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $45 → $25 | $22.60 | +10.62% | 3 | Aug 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $330 → $325 | $308.10 | +5.49% | 15 | Jul 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Sector Perform | $4 → $3 | $0.34 | +782.09% | 8 | Jul 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $425 → $435 | $351.69 | +23.69% | 19 | Jan 29, 2025 |
Boston Scientific
Dec 17, 2025
Maintains: Outperform
Price Target: $125 → $130
Current: $92.95
Upside: +39.86%
Becton, Dickinson and Company
Dec 17, 2025
Maintains: Sector Perform
Price Target: $202 → $210
Current: $196.39
Upside: +6.93%
Johnson & Johnson
Dec 11, 2025
Maintains: Outperform
Price Target: $209 → $230
Current: $209.30
Upside: +9.89%
Edwards Lifesciences
Dec 5, 2025
Maintains: Outperform
Price Target: $95 → $100
Current: $85.32
Upside: +17.21%
Insulet
Nov 21, 2025
Maintains: Outperform
Price Target: $370 → $380
Current: $288.73
Upside: +31.61%
Medtronic
Nov 19, 2025
Maintains: Outperform
Price Target: $111 → $118
Current: $97.72
Upside: +20.75%
Outset Medical
Nov 11, 2025
Maintains: Sector Perform
Price Target: $22 → $17
Current: $3.92
Upside: +333.67%
Teleflex
Nov 7, 2025
Maintains: Sector Perform
Price Target: $135 → $120
Current: $124.87
Upside: -3.90%
Globus Medical
Nov 7, 2025
Maintains: Outperform
Price Target: $88 → $92
Current: $85.79
Upside: +7.24%
Zimmer Biomet Holdings
Nov 6, 2025
Maintains: Outperform
Price Target: $111 → $101
Current: $90.91
Upside: +11.10%
Nov 4, 2025
Maintains: Outperform
Price Target: $150 → $125
Current: $115.51
Upside: +8.22%
Oct 31, 2025
Maintains: Outperform
Price Target: $100 → $85
Current: $66.37
Upside: +28.07%
Oct 22, 2025
Maintains: Outperform
Price Target: $615 → $625
Current: $554.58
Upside: +12.70%
Oct 16, 2025
Reiterates: Outperform
Price Target: $147
Current: $126.86
Upside: +15.88%
Aug 7, 2025
Maintains: Outperform
Price Target: $45 → $25
Current: $22.60
Upside: +10.62%
Jul 30, 2025
Maintains: Outperform
Price Target: $330 → $325
Current: $308.10
Upside: +5.49%
Jul 15, 2025
Maintains: Sector Perform
Price Target: $4 → $3
Current: $0.34
Upside: +782.09%
Jan 29, 2025
Maintains: Outperform
Price Target: $425 → $435
Current: $351.69
Upside: +23.69%